We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
4 own
5 watching
Current Price
$43.31
$0.59
(1.38%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
849.21M
52-Week High
74.38
52-Week Low
31.62
Average Volume
0.06M
Dividend Yield
--
P/E Ratio
100.3473
Market Capitalization849.21M
52-Week High74.38
52-Week Low31.62
Average Volume0.06M
Dividend Yield--
P/E Ratio100.3473
What does the Stockal+Disclaimer.pdf do?
Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Business Wire
19days ago
Cutera, Inc. (Nasdaq: CUTR) ('Cutera' or the 'Company'), a leading provider of aesthetic and dermatology solutions, today announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America. AviClear is the first and only...
Business Wire
1month ago
Cutera, Inc. (Nasdaq: CUTR) ('Cutera' or the 'Company'), a leading provider of aesthetic and dermatology solutions, today announced that the 12-month clinical data related to AviClear, the first and only FDA-cleared energy-based device for the treatment of mild, moderate, and...
PR Newswire
1month ago
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand PR Newswire PALM BEACH, Fla., Oct. 4, 2022 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 4, 2022 /PRNewswire/ -- The laser...
Business Wire
4 months ago
Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that AviClear, the first and only energy device approved in the United States for the treatment of mild, moderate, and severe acne, has secured clearance from Health Canada for the treatment of...
Zolmax
6 months ago
Principal Financial Group Inc. raised its stake in Cutera, Inc. (NASDAQ:CUTR Get Rating) by 25.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 140,238 shares of the medical device companys stock after buying an ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$43.31
$0.59
(1.38%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00